Mr Bukuru Nturubika

School of Pharmacy and Biomedical Sciences

College of Health


Year Citation
2026 Khetan, R., Rajapaksha, W., Nturubika, B. D., Gillam, T. A., Brooks, D. A., Garg, S., . . . Eldi, P. (2026). Targeting F2R/PAR1 with ligand decorated lipid nanocarriers for enhanced drug delivery into ovarian cancer cells. Frontiers in Drug Delivery, 5, 15 pages.
DOI
2025 Hindes, M. T., McElligott, A. M., Best, O. G., Ward, M. P., Selemidis, S., Miles, M. A., . . . Brooks, D. A. (2025). Metabolic reprogramming, malignant transformation and metastasis: Lessons from chronic lymphocytic leukaemia and prostate cancer. Cancer Letters, 611(217441), 217441-1-217441-18.
DOI Scopus13 WoS15 Europe PMC11
2025 Heatlie, J. K., Lazniewska, J., Moore, C. R., Johnson, I. R. D., Nturubika, B. D., Williams, R., . . . Brooks, D. A. (2025). Extracellular Vesicles and Tunnelling Nanotubes as Mediators of Prostate Cancer Intercellular Communication. Biomolecules, 15(1), 23.
DOI Scopus10 WoS9 Europe PMC7
2024 Nturubika, B. D., Guardia, C. M., Gershlick, D. C., Logan, J. M., Martini, C., Heatlie, J. K., . . . Johnson, I. R. D. (2024). Altered expression of vesicular trafficking machinery in prostate cancer affects lysosomal dynamics and provides insight into the underlying biology and disease progression. British Journal of Cancer, 131(8), 1263-1278.
DOI Scopus5 WoS5 Europe PMC5
2024 Nturubika, B. D. D., Logan, J., Johnson, I. R. D., Moore, C., Li, K. L., Tang, J., . . . Brooks, D. A. (2024). Components of the endosome-lysosome vesicular machinery as drivers of the metastatic cascade in prostate cancer. Cancers, 17(1), 1, article no. 43-31.
DOI Scopus4 WoS4 Europe PMC4

Connect With Me

Other Links